| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7305effc496dec13622f0c922f5578db |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76a1a308bcae5c228f17713d2c97af7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f32ba3fdd7f03b0f15a39b4018f4a7a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1dd95c1e7b709644ae071a4f74ee094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c84bafbe5fd28db59f6266b0fab0a77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acf5f069b132ad712b5520f8d2cc4a28 |
| publicationDate |
2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-3074682-A1 |
| titleOfInvention |
COMPOSITIONS IN THE FORM OF AQUEOUS INJECTABLE SOLUTION COMPRISING AMYLINE, AMYLINE RECEPTOR AGONIST OR AMYLINE ANALOGUE AND CO-POLYAMINOACID |
| abstract |
The invention relates to a composition in the form of an injectable aqueous solution, the pH of which is between 6.0 and 8.0, comprising at least: a) amylin, an amylin receptor agonist or a amylin analogue; b) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy, said co-polyamino acid being constituted by glutamic or aspartic units and said hydrophobic radicals Hy being of formula X as follows: c) characterized in that the composition does not comprise a basal insulin whose isoelectric point pi is between 5.8 and 8.5. It also relates to a composition characterized in that it further comprises prandial insulin. |
| priorityDate |
2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |